Executive Order 14273: Lowering Drug Prices by Once Again Putting Americans First

This executive order renews a comprehensive campaign to lower prescription drug prices by prioritizing patient access, transparency, and market competition. It directs federal agencies to reform Medicare drug negotiations, stabilize Part D premiums, and test payment models that better reflect the value of high-cost drugs. The order also targets barriers to generic drug approval, price disparities with foreign markets, and anti-competitive behavior by pharmaceutical manufacturers. With a focus on putting American patients first, the administration seeks to restore savings and accountability across the entire drug supply chain.